drugset / Trial / NCT07462130
An Efficacy and Safety Study of NTB003 in Participants With Thyroid Eye Disease (TED)
Non-randomizedSequentialOpen-labelTreatment
Summary
Multicentre, Phase Ib/II Clinical Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of NTB003 in Participants with Thyroid Eye Disease
Timeline
- Start
- 2026-03-01
- Primary completion
- 2027-05-31
- Completion
- 2028-03-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NTB003 | Unknown | — | Subcutaneous |